![Diagnostic and prognostic value of FDG PET-CT in patients with suspected recurrent thymic epithelial tumors | Scientific Reports Diagnostic and prognostic value of FDG PET-CT in patients with suspected recurrent thymic epithelial tumors | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-021-00003-4/MediaObjects/41598_2021_3_Fig1_HTML.jpg)
Diagnostic and prognostic value of FDG PET-CT in patients with suspected recurrent thymic epithelial tumors | Scientific Reports
![18F-FDG PET/CT for Monitoring the Response of Lymphoma to Radioimmunotherapy | Journal of Nuclear Medicine 18F-FDG PET/CT for Monitoring the Response of Lymphoma to Radioimmunotherapy | Journal of Nuclear Medicine](https://jnm.snmjournals.org/content/jnumed/50/1/8/F2.large.jpg)
18F-FDG PET/CT for Monitoring the Response of Lymphoma to Radioimmunotherapy | Journal of Nuclear Medicine
![FDG‐PET/CT in the management of lymphomas: current status and future directions - El‐Galaly - 2018 - Journal of Internal Medicine - Wiley Online Library FDG‐PET/CT in the management of lymphomas: current status and future directions - El‐Galaly - 2018 - Journal of Internal Medicine - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/670ee159-b761-4ad7-8fb9-b336be7e0bf2/joim12813-fig-0001-m.jpg)
FDG‐PET/CT in the management of lymphomas: current status and future directions - El‐Galaly - 2018 - Journal of Internal Medicine - Wiley Online Library
![FDG‐PET/CT in the management of lymphomas: current status and future directions - El‐Galaly - 2018 - Journal of Internal Medicine - Wiley Online Library FDG‐PET/CT in the management of lymphomas: current status and future directions - El‐Galaly - 2018 - Journal of Internal Medicine - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/dc07ffcd-e705-4ac2-894c-903d23bbb772/joim12813-fig-0003-m.jpg)
FDG‐PET/CT in the management of lymphomas: current status and future directions - El‐Galaly - 2018 - Journal of Internal Medicine - Wiley Online Library
![In Newly Diagnosed Diffuse Large B-Cell Lymphoma, Determination of Bone Marrow Involvement with 18F-FDG PET/CT Provides Better Diagnostic Performance and Prognostic Stratification Than Does Biopsy | Journal of Nuclear Medicine In Newly Diagnosed Diffuse Large B-Cell Lymphoma, Determination of Bone Marrow Involvement with 18F-FDG PET/CT Provides Better Diagnostic Performance and Prognostic Stratification Than Does Biopsy | Journal of Nuclear Medicine](https://jnm.snmjournals.org/content/jnumed/54/8/1244/F3.large.jpg?width=800&height=600&carousel=1)
In Newly Diagnosed Diffuse Large B-Cell Lymphoma, Determination of Bone Marrow Involvement with 18F-FDG PET/CT Provides Better Diagnostic Performance and Prognostic Stratification Than Does Biopsy | Journal of Nuclear Medicine
![Comparison of whole-body diffusion-weighted magnetic resonance and FDG-PET/ CT in the assessment of Hodgkin's lymphoma for staging and treatment response - ecanc Comparison of whole-body diffusion-weighted magnetic resonance and FDG-PET/ CT in the assessment of Hodgkin's lymphoma for staging and treatment response - ecanc](https://ecancer.org/es/journal/article/site/data/images/article/431/can-8-429fig1.gif)
Comparison of whole-body diffusion-weighted magnetic resonance and FDG-PET/ CT in the assessment of Hodgkin's lymphoma for staging and treatment response - ecanc
![Overview and recent advances in PET/CT imaging in lymphoma and multiple myeloma - European Journal of Radiology Overview and recent advances in PET/CT imaging in lymphoma and multiple myeloma - European Journal of Radiology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/fadeb014-054d-4fb3-9baf-6bb0b403ff8b/gr1.jpg)
Overview and recent advances in PET/CT imaging in lymphoma and multiple myeloma - European Journal of Radiology
![The role of PET in the first-line treatment of the most common subtypes of non-Hodgkin lymphoma - The Lancet Haematology The role of PET in the first-line treatment of the most common subtypes of non-Hodgkin lymphoma - The Lancet Haematology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/eb4460e2-9370-4639-aad3-c24167f1b4c0/gr1_lrg.jpg)
The role of PET in the first-line treatment of the most common subtypes of non-Hodgkin lymphoma - The Lancet Haematology
![Spontaneous regression of mantle cell lymphoma: a report of four cases | Cancer Communications | Full Text Spontaneous regression of mantle cell lymphoma: a report of four cases | Cancer Communications | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs40880-018-0306-z/MediaObjects/40880_2018_306_Fig1_HTML.png)
Spontaneous regression of mantle cell lymphoma: a report of four cases | Cancer Communications | Full Text
![FDG PET/CT in the staging of extent of disease in lymphoma. Coronal... | Download Scientific Diagram FDG PET/CT in the staging of extent of disease in lymphoma. Coronal... | Download Scientific Diagram](https://www.researchgate.net/profile/Stanley-Goldsmith/publication/274145433/figure/fig1/AS:433807590465536@1480439197036/FDG-PET-CT-in-the-staging-of-extent-of-disease-in-lymphoma-Coronal-images-left-to.png)
FDG PET/CT in the staging of extent of disease in lymphoma. Coronal... | Download Scientific Diagram
![Preliminary evidence of imaging of chemokine receptor-4-targeted PET/CT with [68Ga]pentixafor in non-Hodgkin lymphoma: comparison to [18F]FDG | EJNMMI Research | Full Text Preliminary evidence of imaging of chemokine receptor-4-targeted PET/CT with [68Ga]pentixafor in non-Hodgkin lymphoma: comparison to [18F]FDG | EJNMMI Research | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13550-020-00681-7/MediaObjects/13550_2020_681_Fig1_HTML.png)
Preliminary evidence of imaging of chemokine receptor-4-targeted PET/CT with [68Ga]pentixafor in non-Hodgkin lymphoma: comparison to [18F]FDG | EJNMMI Research | Full Text
![Proportion of false-positive lesions at interim and end-of-treatment FDG-PET in lymphoma as determined by histology: Systematic review and meta-analysis - European Journal of Radiology Proportion of false-positive lesions at interim and end-of-treatment FDG-PET in lymphoma as determined by histology: Systematic review and meta-analysis - European Journal of Radiology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/14ad0d90-7d40-4d28-9eb6-ac8a06a1cde4/gr2_lrg.jpg)